Under an ophthalmoscope, some retinas reveal something unmistakable: tiny, glistening yellow-white deposits scattered across the surface, resembling scattered crystals. That is the hallmark of Bietti’s Crystalline Dystrophy, a rare and slow-progressing condition documented more frequently in East Asian populations, though not limited to them — patients from Nigeria are usually first identified after a local ophthalmologist notices those characteristic crystals during a routine fundus examination.
The crystals themselves are not really what drives the vision loss — they function more as a visible marker. What genuinely matters is how much of the surrounding retinal tissue has already been affected by the underlying degenerative process, and that is where our evaluation places its focus.

Associate Professor, Vitreo-Retina Surgeon. 10+ Years Experience

Senior Consultant Ophthalmologist & Eye Surgeon· 26+ yrs experience

Consultant Ophthalmologist & Eye Surgeon, MD, DO .16+ Years Experience
Since this condition typically progresses slowly, care centres on regular monitoring to track the pace of change, with regenerative stem cell therapy considered for eligible patients as a supportive measure aimed at preserving whatever retinal tissue remains functionally intact.
“Not directly — they act more as a marker than a cause. It is the thinning of the retina and choroid around them that actually drives the vision decline, and that is what our evaluation and ongoing monitoring focus on.”
”
Generally quite slowly, often spread across many years to decades, though the pace does vary between individuals. That is a significant part of why we recommend ongoing periodic monitoring rather than a single one-time check.”
“It has been documented more often in East Asian populations in published literature, but it is not confined to any one group and does appear elsewhere, including among patients of Nigerian and broader African background.”
“The presence of distinctive crystalline deposits on fundus examination, together with confirmation of a CYP4V2 mutation on genetic testing, is what sets Bietti’s Crystalline Dystrophy apart from other rod-cone dystrophies that can otherwise appear fairly similar on the surface.”
